home / stock / edt:cc / edt:cc news

EDT:CC News and Press, Spectral Medical Inc. From 08/12/25

Stock Information
Company Name: Spectral Medical Inc.
Stock Symbol: EDT:CC
Market: TSXC
Website: spectraldx.com
Menu
EDT:CC EDT:CC Quote EDT:CC Short EDT:CC News EDT:CC Articles EDT:CC Message Board
Get EDT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
EDT:CC - Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% posterior proba...
EDT:CC - Canadian Investment Regulatory Organization Trading Halt - EDT

Canadian Investment Regulatory Organization Trading Halt - EDT Canada NewsWire TORONTO , Aug. 12, 2025 /CNW/ - The following issues have been halted by CIRO: Company: Spectral Medical Inc. TSX Symbol: EDT All Issues: Yes Reason: Pending&...

EDT:CC - Spectral Medical Announces Second Quarter and Provides Corporate Update

Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and ...

EDT:CC - Expected Canadian Company Earnings on Friday, August 8th, 2025

Boralex Inc. Class A Shares (BLX:CA) is expected to report $0.01 for Q2 2025 Algonquin Power & Utilities Corp. (AQN:CA) is expected to report $0.06 for Q2 2025 Dorel Industries Inc. Class A Multiple Voting Shares (DII.A:CA) is expected to report for Q2 2025 dentalcorp Holdings Ltd...
EDT:CC - Expected earnings - Spectral Medical Inc.

Spectral Medical Inc. (EDT:CA) is expected to report for Q2 2025

EDT:CC - Spectral Medical Inc. Announces Filing of Base Shelf Prospectus

TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“ Spectral” or the “Company” ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has filed a preliminary sh...

EDT:CC - Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a fireside chat...
EDT:CC - Spectral Medical Announces First Quarter and Provides Corporate Update

Tigris Trial Enrollment completed Topline results expected to be released in August 2025 Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (ȁ...

EDT:CC - Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive

• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to host Corporate Update Call on May 15, 2...

EDT:CC - Spectral Medical Completes Tigris Trial Enrollment

157 patients enrolled Topline results expected to be released in August 2025 Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (T...
Previous 10 Next 10